These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


102 related items for PubMed ID: 8321021

  • 1. Mutations within the FLR exon of NF1 are rare in myelodysplastic syndromes and acute myelocytic leukemias.
    Ludwig L, Janssen JW, Schulz AS, Bartram CR.
    Leukemia; 1993 Jul; 7(7):1058-60. PubMed ID: 8321021
    [Abstract] [Full Text] [Related]

  • 2. Rare occurrence of mutations of the FLR exon of the neurofibromatosis 1 (NF1) gene in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).
    Preudhomme C, Vachee A, Quesnel B, Wattel E, Cosson A, Fenaux P.
    Leukemia; 1993 Jul; 7(7):1071. PubMed ID: 8321023
    [No Abstract] [Full Text] [Related]

  • 3. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.
    Lee YY, Kim WS, Bang YJ, Jung CW, Park S, Yoon WJ, Cho KS, Kim IS, Jung TJ, Choi IY.
    Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106
    [Abstract] [Full Text] [Related]

  • 4. Analysis of mutations and expression of GAP-related domain of the neurofibromatosis type 1 (NF1) gene in the progression of chronic myelogenous leukemia.
    Nakai H, Misawa S, Horiike S, Taniwaki M, Seriu T, Shimazaki C, Fujii H, Maekawa T, Furukawa T, Abe T.
    Leukemia; 1994 Jun; 8(6):1027-33. PubMed ID: 8207976
    [Abstract] [Full Text] [Related]

  • 5. Exon trap analysis of a NF1 splice-site mutation in a chronic myelomonocytic leukemia patient.
    Ludwig L, Janssen JW, Bartram CR.
    Leukemia; 1995 May; 9(5):922-4. PubMed ID: 7769857
    [Abstract] [Full Text] [Related]

  • 6. Neurofibromatosis 1 gene (NF1) mutation is a rare genetic event in myelodysplastic syndrome regardless of the disease progression.
    Kaneko H, Horiike S, Nakai H, Ueda Y, Nakao M, Hirakawa K, Yokota S, Taniwaki M, Misawa S, Kashima K.
    Int J Hematol; 1995 Apr; 61(3):113-6. PubMed ID: 7599322
    [Abstract] [Full Text] [Related]

  • 7. Absence of rearrangement of the neurofibromatosis 1 (NF1) gene in myelodysplastic syndromes and acute myeloid leukemia.
    Quesnel B, Preudhomme C, Vanrumbeke M, Vachee A, Lai JL, Fenaux P.
    Leukemia; 1994 May; 8(5):878-80. PubMed ID: 8182944
    [Abstract] [Full Text] [Related]

  • 8. Monosomy 7 myelodysplastic syndrome and other second malignant neoplasms in children with neurofibromatosis type 1.
    Maris JM, Wiersma SR, Mahgoub N, Thompson P, Geyer RJ, Hurwitz CG, Lange BJ, Shannon KM.
    Cancer; 1997 Apr 01; 79(7):1438-46. PubMed ID: 9083167
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The prognostic significance of bone marrow levels of neurofibromatosis-1 protein and ras oncogene mutations in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Lu D, Nounou R, Beran M, Estey E, Manshouri T, Kantarjian H, Keating MJ, Albitar M.
    Cancer; 2003 Jan 15; 97(2):441-9. PubMed ID: 12518368
    [Abstract] [Full Text] [Related]

  • 11. [Flt-3/ITD mutation in pediatric leukemia and its clinical significance].
    Wang J, Wang T, Li S, Lin L, Gang Y.
    Ai Zheng; 2007 Jan 15; 26(1):58-63. PubMed ID: 17222369
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Structural integrity and expression of the L3MBTL gene in normal and malignant hematopoietic cells.
    MacGrogan D, Kalakonda N, Alvarez S, Scandura JM, Boccuni P, Johansson B, Nimer SD.
    Genes Chromosomes Cancer; 2004 Nov 15; 41(3):203-13. PubMed ID: 15334543
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A heterozygous frameshift mutation in the Fanconi anemia C gene in familial T-ALL and secondary malignancy.
    Rischewski JR, Clausen H, Leber V, Niemeyer C, Ritter J, Schindler D, Schneppenheim R.
    Klin Padiatr; 2000 Nov 15; 212(4):174-6. PubMed ID: 10994546
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Molecular analysis of neurofibromatosis type 1 mutations.
    Weiming X, Yu Q, Lizhi L, Ponder M, Wallace M, Gangfeng X, Ponder B.
    Hum Mutat; 1992 Nov 15; 1(6):474-7. PubMed ID: 1301957
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.